+91-8668442535

In-Vitro Diagnostics Quality Control Market By Product (Quality Controls, Data Management Solutions, Quality Assurance Services), By Application (Immunochemistry, Clinical Chemistry, Hematology, Coagulation, Molecular Diagnostics, Microbiology, Others) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

Industry Outlook

The global in-vitro diagnostics quality control market was valued at US$ 854.0 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 3.9% during the forecast period from 2018 to 2026. In-vitro diagnostics quality control are tests to validate the efficacy and reliability of the in-vitro diagnostic systems and ensure its accuracy and evaluate the impact of environmental conditions and other things that can affect the test results. Erroneous in-vitro diagnostic testing systems have significant side-effects on the patients. Moreover, it can delay in diagnosis and may also result in improper treatment leading to long-term complications and additional healthcare cost. Moreover, failure to identify the pathogen especially during an outbreak can delay in determining the true cause and thereby lead to inaccurate measures for the same. Poor diagnostic quality also leads to poor patient outcomes, increased mortality and morbidity posing a barrier in public health interventions. Growing usage of in-vitro diagnostic testing for various diseases such as infectious diseases, cardiovascular disorders and oncology testing is the major driver for the growth of in-vitro diagnostics quality control market. Moreover, growing inclination towards personalized medicine and molecular diagnostic to explore knowledge and treatment for rare diseases are boosting use of in-vitro diagnostics, thereby growing the market for in-vitro diagnostics quality control market. 

Get a sample copy for more information

Market Synopsis

In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Quality Controls Segment Accounted for the Largest Share by Product Type  

The in-vitro diagnostics quality control market is segmented in to quality controls, data management solutions, and quality assurance services. In 2017, quality controls segment held the largest share in the market owing to high demand of these products for validating the accuracy and precision of the in-vitro diagnostic tests. Quality control is an important aspect in the clinical and laboratory based testing to ensure safety and accuracy as per standards set by Food and Drug Administration (FDA), European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) and Clinical Laboratory Improvement Amendments (CLIA).

In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

In-vitro diagnostics quality control market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on product type, applications and geography.

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Quality Controls
    o Whole Blood-Based Controls
    o Serum/plasma-based Controls
    o Urine-based controls
    o Others
 • Data Management Solutions
 • Quality Assurance Services

 By Application (2016–2026; US$ Mn)
 • Immunochemistry
 • Clinical Chemistry
 • Hematology
 • Coagulation
 • Molecular Diagnostics
 • Microbiology
 • Others

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of APAC)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of Middle East and Africa)

The in-vitro diagnostics quality control market is studied to understand the current and future trends and dynamics. The study scope includes market size and forecast for all considered segments studied in the report for the period from 2016 to 2026, along with compound annual growth rate (CAGR) for forecast period from 2018 to 2026, 2017 being the considered as the base year. The key players currently engaged in In-vitro diagnostics quality control market include Siemens Healthineers, Thermo Fisher Scientific, Inc., Roche Diagnostics, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Seracare Life Sciences, Inc., Sysmex Corporation, Helena Laboratories, Sun Diagnostics, LLC among others. 


In-Vitro Diagnostics Quality Control Market

Get a sample copy for more information

Key questions answered in this report

  • How the global in-vitro diagnostics quality control market will perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the in-vitro diagnostics quality control market and valuable opportunities for key players?
  • Who are the leading players in the global in-vitro diagnostics quality control market?
  • Which is the leading and fastest region in the global in-vitro diagnostics quality control market?
  • What are drivers and restrains governing the global in-vitro diagnostics quality control market? 
Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Godaddy
Published Date:  Mar 2019
Category:  Medical Devices
Report ID:   59637
Report Format:   PDF
Pages:   120
Rating:    4.2 (66)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support